Adirondack Trust Co. grew its stake in Danaher Co. (NYSE:DHR) by 3.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,635 shares of the conglomerate’s stock after acquiring an additional 78 shares during the quarter. Adirondack Trust Co.’s holdings in Danaher were worth $349,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of DHR. Vanguard Group Inc increased its stake in shares of Danaher by 1.4% in the 3rd quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock worth $4,861,338,000 after acquiring an additional 605,018 shares during the last quarter. Advisors Asset Management Inc. increased its stake in shares of Danaher by 2.8% in the 4th quarter. Advisors Asset Management Inc. now owns 40,082 shares of the conglomerate’s stock worth $4,133,000 after acquiring an additional 1,082 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Danaher by 8.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 29,763 shares of the conglomerate’s stock worth $3,198,000 after acquiring an additional 2,402 shares during the last quarter. Bailard Inc. increased its stake in shares of Danaher by 1.4% in the 4th quarter. Bailard Inc. now owns 65,891 shares of the conglomerate’s stock worth $6,795,000 after acquiring an additional 926 shares during the last quarter. Finally, Wesbanco Bank Inc. increased its stake in shares of Danaher by 2.7% in the 4th quarter. Wesbanco Bank Inc. now owns 35,826 shares of the conglomerate’s stock worth $3,694,000 after acquiring an additional 951 shares during the last quarter. 78.93% of the stock is owned by institutional investors and hedge funds.
In related news, Director Donald J. Ehrlich sold 5,000 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $132.95, for a total transaction of $664,750.00. Following the completion of the transaction, the director now directly owns 100,603 shares in the company, valued at approximately $13,375,168.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Alan G. Spoon sold 1,913 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the transaction, the director now owns 86,863 shares of the company’s stock, valued at $11,250,495.76. The disclosure for this sale can be found here. Insiders have sold a total of 453,448 shares of company stock valued at $59,724,640 over the last 90 days. 11.40% of the stock is currently owned by company insiders.
DHR has been the subject of a number of recent research reports. Janney Montgomery Scott raised their target price on Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Jefferies Financial Group raised their target price on Danaher to $140.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $140.00 price target on shares of Danaher in a report on Monday, March 4th. Zacks Investment Research upgraded Danaher from a “sell” rating to a “hold” rating in a report on Monday, May 6th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $138.00 price target (up from $114.00) on shares of Danaher in a report on Thursday, February 28th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Danaher has an average rating of “Buy” and an average price target of $133.00.
NYSE DHR opened at $137.91 on Wednesday. The firm has a market cap of $98.46 billion, a PE ratio of 30.51, a price-to-earnings-growth ratio of 2.66 and a beta of 0.95. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.18 and a quick ratio of 1.74. Danaher Co. has a twelve month low of $94.59 and a twelve month high of $139.48.
Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. The business had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The company’s revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.99 EPS. As a group, equities analysts expect that Danaher Co. will post 4.77 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s dividend payout ratio (DPR) is 15.04%.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Equities Focus and is the sole property of of Equities Focus. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.equitiesfocus.com/2019/06/12/adirondack-trust-co-buys-78-shares-of-danaher-co-nysedhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: How to Use the New Google Finance Tool
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.